Get started
Author

Jubrail Dahabreh

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
2016 · Johan F Vansteenkiste, Byoung Chul Cho, et al. · The Lancet Oncology · 524
Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
2013 · Johan Vansteenkiste, Marcin Zielinski, et al. · Journal of Clinical Oncology · 325
PDF
Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer
2007 · Vaios Karanikas, Maria Zamanakou, et al. · Cancer Biology & Therapy · 86
PDF
Magrit, a Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of the Recmage-A3 + As15 Cancer Immunotherapeutic As Adjuvant Therapy in Patients with Resected Mage-A3-Positive Non-Small Cell Lung Cancer (Nsclc)
2014 · J.F. Vansteenkiste, B. Cho, et al. · Annals of Oncology · 55
Primary Malignant Melanoma of the Lung: A Case Report
2003 · Apostolos Dountsis, Charalambos Zisis, et al. · World Journal of Surgical Oncology · 54
PDF
Response of malignant thymoma to erlotinib
2008 · C. Christodoulou, S. Murray, et al. · Annals of Oncology · 46
Inflammatory pseudotumor: a controversial entity
1999 · Dahabreh Jubrail, Zisis Charalambos, et al. · European Journal of Cardio-Thoracic Surgery · 37
PDF
Congenital cystic adenomatoid malformation in an adult presenting as lung abscess
2000 · J. Dahabreh, Ch. Zisis, et al. · European Journal of Cardio-Thoracic Surgery · 36
PDF
Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
2015 · EIRINI PAPADOPOULOU, NIKOLAOS TSOULOS, et al. · Oncology Letters · 32
PDF
Cisplatin-Based Three Drugs Combination (NIP) as Induction and Adjuvant Treatment in Locally Advanced Non-small Cell Lung Cancer: Final Results
2008 · Maya Gottfried, Rodryg Ramlau, et al. · Journal of Thoracic Oncology · 30
Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy
2008 · Vaios Karanikas, Stefanos Tsochas, et al. · Cancer Biology & Therapy · 23
PDF
Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas
2008 · Dimitra Vageli, Zoe Daniil, et al. · Lung Cancer · 22
MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) as adjuvant therapy in resected stage IB/II non-small cell lung cancer (NSCLC): from proof-of-concept to phase III trial (MAGRIT)
2009 · T. Eisen, J. Vansteenkiste, et al. · Lung Cancer · 16
Bronchoscopic Needle Aspiration in Mediastinal Staging of Patients with Bronchogenic Carcinoma
1998 · Konstantinos Katis, Georgios Kotrogiannis, et al. · Journal of Bronchology · 15
Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: A novel approach using real-time PCR with melting curve analysis in histopathologic material
2006 · Dimitra Vageli, Zoe Daniil, et al. · Oncology Reports · 14
PDF
hMSH2 and hMLH1 Gene Expression Patterns Differ between Lung Adenocarcinoma and Squamous Cell Carcinoma: Correlation with Patient Survival and Response to Adjuvant Chemotherapy Treatment
2012 · Dimitra P. Vageli, Apostolos Zaravinos, et al. · The International Journal of Biological Markers · 13
PDF
Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center
2020 · Vasiliki E Georgakopoulou, Eleftherios Zygouris, et al. · Cureus · 12
PDF
Prognostic value of the immunohistochemistry markers CD56, TTF‑1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors
2021 · Vasiliki Georgakopoulou, Eleftherios Zygouris, et al. · Molecular and Clinical Oncology · 10
PDF
Desmoid Tumors of the Chest Wall
2006 · Charalambos Zisis, Apostolos Dountsis, et al. · Asian Cardiovascular and Thoracic Annals · 9
Mouse p53-Deficient Cancer Models as Platforms for Obtaining Genomic Predictors of Human Cancer Clinical Outcomes
2012 · Marta Dueñas, Mirentxu Santos, et al. · PLoS ONE · 8
PDF
Surgical Resection of Esthesioneuroblastoma Metastasis to the Chest Wall
2007 · Issa Dahabreh, Dimitrios Janinis, et al. · Journal of Thoracic Oncology · 6
PDF
Multiple bilateral recurrent neurofibromas of the lungs
2003 · Charalambos Zisis, Apostolos Dountsis, et al. · European Journal of Cardio-Thoracic Surgery · 6
PDF
Giant chest wall tumor
2003 · Charalambos Zisis, Apostolos Dountsis, et al. · European Journal of Cardio-Thoracic Surgery · 6
PDF
Gene Expression Signature Is a Potential Predictive Factor for Efficacy of Mage-a3 Antigen-specific Cancer Immunotherapeutic (asci) as Adjuvant Therapy in Resected Stage Ib/ii Non-small Cell Lung Cancer (nsclc)
2008 · J Jassem, Johan Vansteenkiste, et al. · Annals of Oncology · 4
MAGRIT phase III trial in adjuvant NSCLC: MAGE-A3 gene expression frequency on the first 2150 patients screened and demographics of first patients randomized
2009 · Tommaso De Pas, Joo-Hang Kim, et al. · Journal of Thoracic Oncology · 2
Works count: 38
Citation count: 1,394
H-index: 14
I10-index: 18
Year
Topic
Type